APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
The discovery of gene mutations responsible for autosomal dominant Alzheimer's disease has enabled researchers to reproduce in transgenic mice several hallmarks of this disorder, notably Aβ accumulation, though in most cases without neurofibrillary tangles. Mice expressing mutated and wild-type APP as well as C-terminal fragments of APP exhibit variations in exploratory activity reminiscent of behavioral and psychological symptoms of Alzeimer dementia (BPSD). In particular, open-field, spontaneous alternation, and elevated plus-maze tasks as well as aggression are modified in several APP transgenic mice relative to non-transgenic controls. However, depending on the precise murine models, changes in open-field and elevated plus-maze exploration occur in either direction, either increased or decreased relative to controls. It remains to be determined which neurotransmitter changes are responsible for this variability, in particular with respect to GABA, 5HT, and dopamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×
“A five-fold transgenic model with Swedish/Florida/London mutations on APP and M146L and L286V mutations on PS1 has been generated with the murine Thy1 promoter (Oakley et al., 2006).”
BackgroundInfluentialAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 3×
“…murine Thy1 yes Moechars et al., 1999b APP/SWE/Ckm Swedish murine Ckm no Sugarman et al., 2002 APP/IND TgPDAPP Indiana platelet-derived PDGFβ yes Games et al., 1995 APP695LD London murine Thy1 yes Moechars et al., 1999b APP/LD-PDGF London platelet-derived PDGFβ yes Qin et al., 2000 APP/DU…”
BackgroundInfluentialLyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 10×
“…by patients with Alzheimer's disease (Chung and Cummings, 2000; Daffner et al., 1992; Frisoni et al., 1999; Hart et al., 2003; Lanari et al., 2006; Lyketsos et al., 2002; Petry et al., 1988; Senanarong et al., 2004), one expects murine models to show hypoactivity, which may be attributed to…”
BackgroundInfluentialMucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 11×
“Two APP/SWE/IND constructs driven by the platelet-derived PDGFβ promoter (J9 and J20 lines) also contain Aβ plaques (Mucke et al., 2000; Palop et al., 2003), as well as mice with a human/mouse chimeric APP695SWE/IND/tet transgene regulated by the tetracycline-responsive promoter of pTetSplice (Jankowsky et al., 2005b).”
BackgroundInfluentialIwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · cited 1×
“As seen in Alzheimer brain (Iwatsubo et al., 1994), diffuse plaques in APP695SWE mice contain Aβ42 and mature plaques Aβ42 and Aβ40 (Harigaya et al., 2006; Kawarabayashi et al., 2001; Terai et al., 2001).”
BackgroundJankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · cited 11×
“Likewise, no Aβ plaques were observable in APP695TRImyc mice (Tg1130H), expressing a triple mutation (V717L, V721A, M722V) with a 3'-myc tag driven by the hamster Prp promoter (Hsiao et al., 1995).”
BackgroundMethodInfluentialTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285 · cited 1×
“In view of the presence of Aβ plaques or APP overexpression in neocortex, it is reasonable to suppose a role for the prefrontal cortex in mediating this phenotype, since anomalies in prefronto-cortical-basal ganglia circuits are known to cause apathy (Levy and Dubois, 2006).”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 5×
“Detergentinsoluble Congo-red positive Aβ plaques were visible in APP695SWE mice as early as 7 months of age and increased with time (Kawarabayashi et al., 2001; Westerman et al., 2002).”
BackgroundInfluentialBorchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · cited 2×
“A second co-injected line contains Swedishmutated APP combined with a PS1/L166P mutation driven by the mouse Thy1 promoter, containing Aβ plaques and gliosis (Radde et al., 2006).”
BackgroundChishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 13×
“…by the hamster Prp promoter (Chishti et al., 2001; Janus et al., 2000), showing Aβ plaques as early as 3 months of age (Bellucci et al., 2006; Chishti et al., 2001; Janus et al., 2000), together with early onset angiopathy (Domnitz et al., 2005) and activated microglia and astrocytes…”
BackgroundInfluentialImpaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946 · cited 3×
“…mutated or wildtype (WT) APP genes with or without mutated PS1 Mouse name Activity References APP695SWE (Tg2576) ↑ or normal Arendash et al., 2004; Chapman et al., 1999; Comery et al., 2005; Deacon et al., 2008; Dineley et al., 2002; Gil-Bea et al., 2007; Gorman and Yellon, 2010; Holcomb et…”
BackgroundSmith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892 · cited 1×
“The assay is also sensitive to gene inactivation of corticotropin releasing factor (Smith et al., 1998), 5HT (Tecott et al., 1998), and dopamine (Dulawa et al., 1999) receptors, as well as the GT2 subtype of GTPase activating protein (Schmalzigaug et al., 2009).”
MethodCharacterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · cited 1×
“APP695SWE/co+PS1/ΔE9 mice harbor Aβ plaques at 6 months of age (Garcia-Alloza et al., 2006; Jankowsky et al., 2004) and possess fewer capillary segments than controls in neocortical white matter (Lee et al., 2005).”
BackgroundTakahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 637 · cited 2×
“Moreover, transgenic mice overexpressing either Aβ40 or Aβ42 in the form of fusion proteins with the BRI protein driven by the murine Prp promoter have been generated (McGowan et al., 2005).”
BackgroundJawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.027 · Cited by 623 · cited 18×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Mouse name Activity References APP/C104 normal Nalbantoglu et al., 1997 APP/C100-Flag normal Berger-Sweeney et al., 1999 APP/C100/IND ↑ Boon et al., 2010 APP/C100/WT ↑ Boon et al., 2010 APP/C99 ↓ Lalonde et al., 2002a APP695SWE+PS1/M14…”
BackgroundInfluentialHalagappa, V. K. M., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., LaFerla, F. M., & Mattson, M. P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.019 · Cited by 580 · cited 4×
“Yet the opposite pattern of hypoactivity was noted at 6 (Pietropaolo et al., 2009) and 7 (Nelson et al., 2007) months, as well as 10 and 17 (Halagappa et al., 2007), 12 (Arsenault et al., 2011), or 15 (Gulinello et al., 2009) months, with no effect found at 8 (Ojha et al., 2011).”
BackgroundResultInfluentialOhno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., & Disterhoft, J. F. (2004) · Neuron · doi:10.1016/s0896-6273(03)00810-9 · Cited by 549
Environmental Enrichment Mitigates Cognitive Deficits in a Mouse Model of Alzheimer's Disease
Jankowsky, J. L., Melnikova, T., Fadale, D. J., Xu, G. M., Slunt, H. H., Gonzales, V., Younkin, L. H., Younkin, S. G., Borchelt, D. R., & Savonenko, A. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5080-04.2005 · Cited by 517 · cited 5×
“…driven by the platelet-derived PDGFβ promoter (J9 and J20 lines) also contain Aβ plaques (Mucke et al., 2000; Palop et al., 2003), as well as mice with a human/mouse chimeric APP695SWE/IND/tet transgene regulated by the tetracycline-responsive promoter of pTetSplice (Jankowsky et al., 2005b).”
BackgroundMethodInfluentialThe Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-21 · Cited by 513
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502 · cited 1×
“Amyloid angiopathy led to weakened vessel walls, aneurysm, vasculitis, and hemorrhage (Beckmann et al., 2011; Calhoun et al., 1999; Winkler et al., 2001), as well as a reduction in their vasodilatory properties (Mueggler et al., 2002, 2003).”
BackgroundGuo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Nature Medicine · doi:10.1038/4789 · Cited by 489
The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi, P., Hansen, L. A., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000129697.01779.0a · Cited by 477
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418
Probing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413
Calhoun, M. E., Burgermeister, P., Phinney, A. L., Stalder, M., Tolnay, M., Wiederhold, K.-H., Abramowski, D., Sturchler-Pierrat, C., Sommer, B., Staufenbiel, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14088 · Cited by 410 · cited 1×
“Amyloid angiopathy led to weakened vessel walls, aneurysm, vasculitis, and hemorrhage (Beckmann et al., 2011; Calhoun et al., 1999; Winkler et al., 2001), as well as a reduction in their vasodilatory properties (Mueggler et al., 2002, 2003).”
BackgroundNeuropsychological detection and characterization of preclinical Alzheimer’s disease
Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., & Stern, Y. (1995) · Neurology · doi:10.1212/wnl.45.5.957 · Cited by 409 · cited 1×
“…of factual information (declarative memory) is found for verbal and spatial items (Amieva et al., 2005; Graham et al., 2004; Helmes and Ostbye 2002; Jacobs et al., 1995; Kessels et al., 2005; Lee et al., 2003), whereas procedural memory is relatively spared, evaluated in pursuit-rotor (Eslinger…”
BackgroundPalop, J. J., Jones, B., Kekonius, L., Chin, J., Yu, G.-Q., Raber, J., Masliah, E., & Mucke, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133381100 · Cited by 402 · cited 2×
“Two APP/SWE/IND constructs driven by the platelet-derived PDGFβ promoter (J9 and J20 lines) also contain Aβ plaques (Mucke et al., 2000; Palop et al., 2003), as well as mice with a human/mouse chimeric APP695SWE/IND/tet transgene regulated by the tetracycline-responsive promoter of pTetSplice…”
BackgroundCasas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400
Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 1×
“The APP751SWE/LD +PS1/M146L mice have Aβ plaques as early as 2.5 months of age and age-related microglial activation, first with the appearance of a phagocytic followed by a cytotoxic phenotype (Jimenez et al., 2008), and pyramidal cell loss in hippocampus (Schmitz et al., 2004).”
BackgroundInfluentialDavis, J., Xu, F., Deane, R., Romanov, G., Previti, M. L., Zeigler, K., Zlokovic, B. V., & Van Nostrand, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312946200 · Cited by 373 · cited 33×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Mouse name Activity References APP/C104 normal Nalbantoglu et al., 1997 APP/C100-Flag normal Berger-Sweeney et al., 1999 APP/C100/IND ↑ Boon et al., 2010 APP/C100/WT ↑ Boon et al., 2010 APP/C99 ↓ Lalonde et al., 2002a APP695SWE+PS1/M14…”
BackgroundMethodInfluentialSequence of Aβ-protein deposition in the human medial temporal lobe
Thal, D. R., Rüb, U., Schultz, C., Sassin, I., Ghebremedhin, E., Del Tredici, K., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.733 · Cited by 370
Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., & Diamond, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03186-3 · Cited by 349
Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice
Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65423-5 · Cited by 345 · cited 1×
“As seen in Alzheimer brain, neuritic plaques are surrounded by astrocytes and activated microglia and tau is hyperphosphorylated (Bornemann et al., 2001; Stalder et al., 1999; Sturchler-Pierrat et al., 1997).”
BackgroundTransgenic mouse models of Alzheimer’s disease.
Elder, G. A., Gama Sosa, M. A., & De Gasperi, R. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20159 · Cited by 336
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316
Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4236-05.2006 · Cited by 305 · cited 2×
“Indeed, APP751SWE mice were more active than controls in the open-field at 3 (Senechal et al., 2008), 10 (Heneka et al., 2006), and 24 months (Dumont et al., 2004).”
BackgroundA decade of modeling Alzheimer's disease in transgenic mice
MCGOWAN, E., ERIKSEN, J., & HUTTON, M. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.03.007 · Cited by 287 · cited 1×
“…and Zahs, 2010; Duyckaerts et al., 2008; German and Eisch, 2004; Gimenez-Llort et al., 2007; Howlett and Richardson, 2009; Kokjohn and Roher, 2009; McGowan et al., 2006; Mineur et al., 2005; Morgan, 2003; Obulesu and Rao, 2010; Sant'Angelo et al., 2003; Scearce-Levie, 2011; Spires and Hyman,…”
Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse
Gordon, M. N., Holcomb, L. A., Jantzen, P. T., DiCarlo, G., Wilcock, D., Boyett, K. W., Connor, K., Melachrino, J., O'Callaghan, J. P., & Morgan, D. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7754 · Cited by 247
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240 · cited 1×
“Excessive aggression may be due to degeneration of brainstem 5-hydroxytryptamine (5HT) neurons, known to influence this symptom (Hardy et al., 1985; Lyness et al., 2003; Whitford 1986).”
BackgroundGalvan, V., Gorostiza, O. F., Banwait, S., Ataie, M., Logvinova, A. V., Sitaraman, S., Carlson, E., Sagi, S. A., Chevallier, N., Jin, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509695103 · Cited by 239
Jankowsky, J. L., Slunt, H. H., Gonzales, V., Savonenko, A. V., Wen, J. C., Jenkins, N. A., Copeland, N. G., Younkin, L. H., Lester, H. A., Younkin, S. G., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020355 · Cited by 237
Lanz, T. A., Carter, D. B., & Merchant, K. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00079-2 · Cited by 227
Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease
Ashe, K. H. (2001) · Learning & Memory · doi:10.1101/lm.43701 · Cited by 224 · cited 1×
“…have appeared on murine Alzheimer models, mainly useful in understanding the impact of amyloid formation on learning or neurobiological processes (Ashe, 2001; Ashe and Zahs, 2010; Duyckaerts et al., 2008; German and Eisch, 2004; Gimenez-Llort et al., 2007; Howlett and Richardson, 2009; Kokjohn…”
BackgroundMassaad, C. A., Washington, T. M., Pautler, R. G., & Klann, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902714106 · Cited by 223 · cited 3×
“…other experimenters reported no change with this model in the open-field (Arendash et al., 2004; Chapman et al., 1999; Comery et al., 2005; Dineley et al., 2002; Massaad et al., 2009; Scholtzova et al., 2009) or Y-maze (Arendash et al., 2004; Holcomb et al., 1998, 1999; Middei et al., 2004).”
BackgroundBondolfi, L., Calhoun, M., Ermini, F., Kuhn, H. G., Wiederhold, K.-H., Walker, L., Staufenbiel, M., & Jucker, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00515.2002 · Cited by 213
Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., & Gonzalez, M. I. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.029 · Cited by 212
Dineley, K. T., Xia, X., Bui, D., Sweatt, J. D., & Zheng, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200164200 · Cited by 212 · cited 19×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Mouse name Activity References APP/C104 normal Nalbantoglu et al., 1997 APP/C100-Flag normal Berger-Sweeney et al., 1999 APP/C100/IND ↑ Boon et al., 2010 APP/C100/WT ↑ Boon et al., 2010 APP/C99 ↓ Lalonde et al., 2002a APP695SWE+PS1/M14…”
BackgroundInfluentialLiu, Y., Yoo, M.-J., Savonenko, A., Stirling, W., Price, D. L., Borchelt, D. R., Mamounas, L., Lyons, W. E., Blue, M. E., & Lee, M. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4218-08.2008 · Cited by 206 · cited 1×
“Due to Aβ deposits in striatum (Perez et al., 2005), neuronal loss has been reported there (Richner et al., 2009), along with decreased 5HT neurons in raphe and decreased noradrenergic neurons in locus coeruleus (Liu et al., 2008).”
BackgroundMoechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00468.x · Cited by 201
Aggleton, J., Neave, N., Nagle, S., & Sahgal, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07270.1995 · Cited by 196 · cited 1×
“…have been reported in rats with lesions in the septum (Clody and Carlton, 1969), basal forebrain magnocellular nucleus (Murray and Fibiger, 1986), anterior thalamus (Aggleton et al., 1995), medial prefrontal cortex (Divac et al., 1975), and prelimbic cortex (Delatour and Gisquet-Verrier, 1996).”
BackgroundHolthoff, V. A., Beuthien-Baumann, B., Kalbe, E., Lüdecke, S., Lenz, O., Zündorf, G., Spirling, S., Schierz, K., Winiecki, P., Sorbi, S., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.035 · Cited by 190 · cited 3×
“Alzheimer patients characterized by apathy had lower fluorodeoxyglucose (FDG) uptake in medial prefrontal cortex than a subgroup not displaying this sign (Holthoff et al., 2005; Marshall et al., 2007).”
BackgroundLüth, H.-J., Holzer, M., Gärtner, U., Staufenbiel, M., & Arendt, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02758-5 · Cited by 183 · cited 1×
“A further resemblance between human (Lüth et al., 2001, 2002) and murine (Lüth et al., 2001) pathology is the overexpression of induced and endothelial forms of nitric oxide synthase (iNOS and eNOS) accompanying astrocytosis.”
BackgroundMcLellan, M. E., Kajdasz, S. T., Hyman, B. T., & Bacskai, B. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02212.2003 · Cited by 174
NEUROBEHAVIORAL AND NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER'S DISEASE
Chung, J. A., & Cummings, J. L. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70228-0 · Cited by 174 · cited 8×
“In view of the apathy often displayed by patients with Alzheimer's disease (Chung and Cummings, 2000; Daffner et al., 1992; Frisoni et al., 1999; Hart et al., 2003; Lanari et al., 2006; Lyketsos et al., 2002; Petry et al., 1988; Senanarong et al., 2004), one expects murine models to show…”
BackgroundInfluentialNELSON, R., GUO, Z., HALAGAPPA, V, PEARSON, M., GRAY, A., MATSUOKA, Y., BROWN, M., MARTIN, B., IYUN, T., & MAUDSLEY, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.037 · Cited by 173 · cited 4×
“Yet the opposite pattern of hypoactivity was noted at 6 (Pietropaolo et al., 2009) and 7 (Nelson et al., 2007) months, as well as 10 and 17 (Halagappa et al., 2007), 12 (Arsenault et al., 2011), or 15 (Gulinello et al., 2009) months, with no effect found at 8 (Ojha et al., 2011).”
BackgroundResultInfluentialLalonde, R., Kim, H. D., Maxwell, J. A., & Fukuchi, K. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.028 · Cited by 170
Self-citationScholtzova, H., Kascsak, R. J., Bates, K. A., Boutajangout, A., Kerr, D. J., Meeker, H. C., Mehta, P. D., Spinner, D. S., & Wisniewski, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5715-08.2009 · Cited by 166 · cited 3×
“…other experimenters reported no change with this model in the open-field (Arendash et al., 2004; Chapman et al., 1999; Comery et al., 2005; Dineley et al., 2002; Massaad et al., 2009; Scholtzova et al., 2009) or Y-maze (Arendash et al., 2004; Holcomb et al., 1998, 1999; Middei et al., 2004).”
BackgroundThe role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice
Wegiel, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00181-0 · Cited by 159
Left frontotemporal hypoperfusion is associated with aggression in patients with dementia
Hirono, N., Mega, M. S., Dinov, I. D., Mishkin, F., & Cummings, J. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.861 · Cited by 153
Arendash, G. W., Lewis, J., Leighty, R. E., McGowan, E., Cracchiolo, J. R., Hutton, M., & Garcia, M. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.081 · Cited by 127
Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice
Lalonde, R., Kim, H. D., & Fukuchi, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.069 · Cited by 121 · cited 6×
“As with the APP695SWE model, variable results are found in younger APP695SWE/co+PS1/ΔE9 mice, with open-field hyperactivity detected at 8 months (Hoojimans et al., 2009), but not at 7 (Lalonde et al., 2004), 9 (Frye and Walf, 2008), or 10 (Hartmann et al., 2010).”
BackgroundResultSelf-citationFilali, M., & Lalonde, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.066 · Cited by 121 · cited 9×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Mouse name Activity References APP/C104 normal Nalbantoglu et al., 1997 APP/C100-Flag normal Berger-Sweeney et al., 1999 APP/C100/IND ↑ Boon et al., 2010 APP/C100/WT ↑ Boon et al., 2010 APP/C99 ↓ Lalonde et al., 2002a APP695SWE+PS1/M14…”
BackgroundSelf-citationFaure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112 · cited 22×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Mouse name Activity References APP/C104 normal Nalbantoglu et al., 1997 APP/C100-Flag normal Berger-Sweeney et al., 1999 APP/C100/IND ↑ Boon et al., 2010 APP/C100/WT ↑ Boon et al., 2010 APP/C99 ↓ Lalonde et al., 2002a APP695SWE+PS1/M14…”
BackgroundInfluentialInflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Alexandru, A., Jagla, W., Graubner, S., Becker, A., Bäuscher, C., Kohlmann, S., Sedlmeier, R., Raber, K. A., Cynis, H., Rönicke, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1794-11.2011 · Cited by 102
Wirths, O., Breyhan, H., Schäfer, S., Roth, C., & Bayer, T. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.004 · Cited by 97
Kuo, Y.-M., Beach, T. G., Sue, L. I., Scott, S., Layne, K. J., Kokjohn, T. A., Kalback, W. M., Luehrs, D. C., Vishnivetskaya, T. A., Abramowski, D., et al. (2001) · Molecular Medicine · doi:10.1007/bf03401867 · Cited by 90
Bast, T., Zhang, W.-N., & Feldon, J. (2001) · Psychopharmacology · doi:10.1007/s002130100775 · Cited by 73 · cited 1×
“…since GABAA receptor antagonists increase motor activity in rats, for example picrotoxin injected at subconvulsive doses either in the periphery (Chang et al., 2004) or directly into the hippocampus (Bast et al., 2001), amygdala (Chang et al., 2004), or nucleus accumbens (Morgenstern et al., 1984).”
BackgroundIncreased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease
Alexander, G., Hanna, A., Serna, V., Younkin, L., Younkin, S., & Janus, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.016 · Cited by 51 · cited 1×
“Male APP695SWE mice (Tg2576) had shorter latencies before the first attack towards an intruder and initiated more attacks than agematched male controls (Alexander et al., 2011).”
BackgroundRichner, M., Bach, G., & West, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.025 · Cited by 20
Cited by
Kim, D.-G., Krenz, A., Toussaint, L. E., Maurer, K. J., Robinson, S.-A., Yan, A., Torres, L., & Bynoe, M. S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0467-5 · Cited by 330
Richard, B. C., Kurdakova, A., Baches, S., Bayer, T. A., Weggen, S., & Wirths, O. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143120 · Cited by 142
“A variety of different transgenic mouse models overexpressing human amyloid- precursor protein (A PP) has been generated during the last 15 years, reflecting various aspects of human pathology [1, 2].”
BackgroundBhattacharya, S., Haertel, C., Maelicke, A., & Montag, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089454 · Cited by 142
Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis
Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0446-8 · Cited by 90
Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0496-6 · Cited by 65
Metadata
- Authors
- Lalonde, R., Fukuchi, K., & Strazielle, C.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 36
- Issue
- 5
- Pages
- 1357-1375
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1995397757
- Cited by
- 62
- References
- 79
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.